Product/Composition:- | Entecavir |
---|---|
Strength:- | 0.5 mg, 1 mg |
Form:- | Tablet |
Reference Brands:- | Baraclude® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Entecavir Tablets (Baraclude® generic) are oral antivirals used for chronic hepatitis B. Available in 0.5 mg and 1 mg strengths, manufactured under EU-GMP/USFDA standards. Ideal for B2B supply, licensing, and public health tenders with full CTD support.
Entecavir Tablets (Baraclude® generic) are oral antivirals used to treat chronic hepatitis B infections. Available in 0.5 mg and 1 mg strengths, they inhibit HBV polymerase to reduce viral replication. Manufactured under EU-GMP and USFDA-certified facilities, Entecavir is offered for B2B supply, licensing, and government tenders. The product comes with full CTD dossiers, stability data, and regulatory support. Widely accepted in the US and EU markets, Entecavir is a key product for public health tenders and antiviral portfolios focused on hepatitis B control programs.